The famous Chinese military general, strategist and philosopher Sun Tzu once said, “Strategy without tactics is the slowest route to victory. Tactics without strategy is the noise before defeat.”
In an overall inflation fighting strategy, many investors fail to incorporate small-cap stocks as part of the many tactics to preserve wealth. That’s probably because investing in small caps or even mid caps is not always easy. There are thousands of small-cap stocks and even isolating only the bottom 20 percent of small-cap names with the lowest price-to-book ratio results in several hundred stocks, which can be daunting for investors.
10 Best Financial Stocks To Watch For 2015: MannKind Corporation(MNKD)
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States, Europe, and Asia. Its lead product candidate, AFREZZA Inhalation Powder, an ultra rapid-acting insulin that is in Phase III clinical trials for the treatment of diabetes for the control of hyperglycemia. The company also develops MKC1106-MT, an investigational cancer immunotherapy product, which is in Phase II clinical trials for the treatment of adults with type 1 or type 2 diabetes; and MKC204, which is in preclinical development stage for the treatment of malignancies and inflammatory diseases. In addition, its products include MKC253 (GLP-1), a Phase I clinical trials product for the treatment of type 2 diabetes; MKC1106-PP, a Phase I clinical trials product for diverse tumor types, metastatic disease, and/or progressive and refractory disease; and MKC180, an obesity compound and MKC1106-NS , a cancer immunotherapy product that are in preclinical trials. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.
Advisors' Opinion:- [By Sean Williams]
What: Shares of MannKind (NASDAQ: MNKD ) , a biopharmaceutical company focused on developing therapeutic products to treat diabetes and cancer, were absolutely whipsawed following the release of the Food and Drug Administration's decision to approve its inhaled insulin therapy, Afrezza, for patients with type 1 and type 2 diabetes. Shares surged nearly 5% immediately following the late-day approval, then collapsed as much as 26% from its high of the day to ultimately finish lower by 5.5%. Shares have since regained a little ground in after-hours trading.
- [By Sean Williams]
One step at a time
Given the tripling we've seen in shares of biotech company MannKind (NASDAQ: MNKD ) over just the past six months, you'd almost assume that investors have written an approval from the Food and Drug Administration for inhalable insulin Afrezza as a certainty. MannKind has received ample backing from its CEO, Alfred Mann, who helped arrange for a large secondary offering, in which his own company, the Mann Group, purchased 40 million shares of MannKind stock. In addition, the company is getting close to being done with a new round of patient trials for Afrezza, so investor excitement is building.
Top Mid Cap Stocks To Buy Right Now: NETGEAR Inc.(NTGR)
NETGEAR, Inc. engages in the design, development, marketing, and sale of networking products. The company offers home networking, storage, and digital media products to connect users with the Internet and their content and devices; networking, storage, and security solutions to commercial businesses; and whole home networking solutions to service providers for sale to their customers. Its products include commercial business networking products consisting of Ethernet switches, wireless controllers, Internet security appliances, and network attached storage devices; broadband access products, such as routers, gateways, IP telephony products, and media servers; and network connectivity products comprising wireless access points, wireless network interface cards and adapters, Ethernet network interface cards and adapters, media adapters, powerline adapters and bridges, and multimedia over coax alliance standard adapters and bridges. The company produces its products through t hird-party manufacturers. NETGEAR, Inc. markets its products primarily through retailers, online retailers, wholesale distributors, direct market resellers, value added resellers, and broadband service providers worldwide. NETGEAR, Inc. was founded in 1996 and is headquartered in San Jose, California.
Advisors' Opinion:- [By Steve Symington]
What:�Shares of Netgear (NASDAQ: NTGR ) dropped more than 11% in Friday's trading after the networking equipment specialist reported mixed second-quarter results and disappointing forward-margin guidance.
- [By Seth Jayson]
Netgear (Nasdaq: NTGR ) is expected to report Q2 earnings on July 25. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Netgear's revenues will grow 10.2% and EPS will contract -12.5%. - [By Steve Symington and Erin Miller]
Early last week, Fool contributor Steve Symington wrote that he would soon buy shares of Netgear (NASDAQ: NTGR ) in his personal portfolio.
Top Mid Cap Stocks To Buy Right Now: Silicon Image Inc.(SIMG)
Silicon Image, Inc. provides wireless and wired high-definition (HD) connectivity solutions that enable the distribution and presentation of HD content for consumer electronics, mobile, and personal computer (PC) markets. It delivers its technology via semiconductor and intellectual property products. The company?s consumer electronics products include high-definition multimedia interface (HDMI) port processors, HDMI and mobile high-definition link (MHL) transmitters, MHL-to-HDMI bridges, and HDMI receiver products; PC products comprise MHL/HDMI-to-HDMI bridges and digital visual interface receivers; and storage products consist of a line of serial advanced technology attachment controllers used in PC, DVR, and network attached storage applications. Its products are deployed by the electronics manufacturers in various devices, such as desktop and notebook PCs, DTVs, Blu-ray disc players, and audio-video receivers, as well as mobile phones, tablets, and digital cameras. The company, through its subsidiaries, provides manufacturers comprehensive standards interoperability and compliance testing services; and acts as an agent for promoting and administering HDMI and MHL specifications, and for licensing the serial port memory technology memory interface specification. It sells its products to original product manufacturers worldwide through direct sales force, as well as through a network of distributors and manufacturer?s representatives. The company has operations in the United States, Taiwan, Japan, China, and Korea, as well as Europe and internationally. Silicon Image, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
Advisors' Opinion:- [By John Udovich]
We have recently added small cap video chip stock Pixelworks, Inc (NASDAQ: PXLW) to our SmallCap Network Elite Opportunity (SCN EO)�as it stands to benefit from the growth in connecting HD quality video across all mobile device platforms, as well as Smart TVs; but Silicon Image, Inc (NASDAQ: SIMG) and Sigma Designs, Inc (NASDAQ: SIGM) are also providing chips for the video or entertainment markets. Moreover, all three of these small cap stocks have recently reported earnings that might leave you feeling even more bullish.
- [By Bryan Murphy]
Quick - what do Simon Property Group Inc. (NYSE:SPG), Dr. Pepper Snapple Group Inc. (NYSE:DPS), and Silicon Image, Inc. (NASDAQ:SIMG) have in common? If you said absolutely nothing, you'd be about 99% right. There's one common thing between SIMG, SPG, and DPS right now, however. What's that? All three stocks are on my personal "buy" list this week.
Top Mid Cap Stocks To Buy Right Now: Pinnacle Entertainment Inc.(PNK)
Pinnacle Entertainment, Inc. owns, develops, and operates casinos, and related hospitality and entertainment facilities in the United States. It operates casinos, such as L'Auberge du Lac in Lake Charles, Louisiana; River City Casino and Lumiere Place in St. Louis, Missouri; Boomtown New Orleans in New Orleans, Louisiana; Belterra Casino Resort in Vevay, Indiana; Boomtown Bossier City in Bossier City, Louisiana; and Boomtown Reno in Reno, Nevada. The company also operates River Downs racetrack in southeast Cincinnati, Ohio. As of May 26, 2011, it operated seven casinos and one racetrack. The company was formerly known as Hollywood Park, Inc. and changed its name to Pinnacle Entertainment, Inc. in February 2000. Pinnacle Entertainment, Inc. was founded in 1935 and is based in Las Vegas, Nevada.
Advisors' Opinion:- [By Sean Williams]
Time to make the switch
If I could name a sector that I'd certainly tread lightly around considering that consumers are tightening their wallets, it would be the casino sector. Casino companies rely on loose wallets and vacations to drive profits. This is why I feel it could be the time to say goodbye to casino and race track operator Pinnacle Entertainment (NYSE: PNK ) near its 52-week high. - [By Dan Radovsky]
Pinnacle Entertainment (NYSE: PNK ) has reached an agreement in principle with the Bureau of Competition of the Federal Trade Commission that would allow the company to complete its proposed acquisition of Ameristar Casinos (NASDAQ: ASCA ) , Pinnacle announced today.
Top Mid Cap Stocks To Buy Right Now: Fonar Corporation(FONR)
FONAR Corporation engages in the research, development, production, marketing, and service of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases. It provides Upright Multi-positional MRI scanners, which allow patients to be scanned in a weight-bearing condition, such as standing, sitting, or bending in any position that causes symptoms; and FONAR 360 MRI scanner, a diagnostic scanner. The company, through its wholly owned subsidiary, Health Management Corporation of America, also offers management services to imaging facilities, including development, administration, and leasing of office space, facilities, and medical equipment; provision of supplies; staffing, training, and supervision of non-medical personnel; legal services; accounting, billing, and collection; and the development and implementation of practice growth and marketing strategies. It serves private diagnostic imaging centers and hospitals. As of June 30, 2011, the c ompany managed 10 diagnostic imaging facilities located in the states of New York and Florida. FONAR Corporation was founded in 1978 and is based in Melville, New York.
Advisors' Opinion:- [By Monica Gerson]
Breaking news
NASDAQ OMX Group (Nasdaq: NDAQ) and Borsa Istanbul A.S. have today concluded a wide-ranging agreement, which includes the delivery of market-leading technologies and advisory services to Borsa Istanbul, and NASDAQ OMX taking an equity stake in Borsa Istanbul. To read the full news, click here. Acacia Research (NASDAQ: ACTG) announced today that its Bolt MRI Technologies LLC subsidiary has entered into an agreement with Fonar Corporation (NASDAQ: FONR). To read the full news, click here. Douglas Emmett, (NYSE: DEI) announced that William Kamer will be retiring from full time service as its Chief Investment Officer effective January 31, 2014. Mr. Kamer will continue to be employed by Douglas Emmett as a Senior Advisor. To read the full news, click here. Acacia Research (NASDAQ: ACTG) announced today that its Brandywine Communications Technologies LLC subsidiary has entered into a settlement and patent license agreement with Alcatel-Lucent USA (NYSE: ALU). To read the full news, click here.Posted-In: Benchmark US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets
Top Mid Cap Stocks To Buy Right Now: The Bon-Ton Stores Inc.(BONT)
The Bon-Ton Stores, Inc., through its subsidiaries, operates department stores in the mid-size and metropolitan markets of the United States. Its stores offer brand-name fashion apparel and accessories for women, men, and children, as well as provide cosmetics, home furnishings, and footwear. As of November 1, 2011, the company operated 275 stores under various nameplates, including the Bon-Ton, Bergner?s, Boston Store, Carson Pirie Scott, Elder-Beerman, Herberger?s, and Younkers in 23 northeastern, midwestern, and upper Great Plains states; and under the Parisian nameplate in Detroit, Michigan. The Bon-Ton Stores, Inc. was founded in 1898 and is headquartered in York, Pennsylvania.
Advisors' Opinion:- [By Peter Graham]
The Q1 2014 earnings report for troubled J.C. Penney Company, Inc (NYSE: JCP), a peer of other department store stocks like Kohl's Corporation (NYSE: KSS), The Bon-Ton Stores, Inc (NASDAQ: BONT) and Nordstrom, Inc (NYSE: JWN), is scheduled for after the market closes on Thursday. Aside from the J.C. Penney Company's earnings report, it should be said that�Kohl's Corporation will report Q1 2014 when the market opens on Thursday; Nordstrom will report earnings after the market closes on Thursday; and The Bon-Ton Stores will report Q1 2014 earnings on Thursday, May 22nd before the market opens. However, all eyes will be on the J.C. Penney Company earnings report to see if there are any signs the company has turned itself around from the ill-fated�leadership of CEO Ron Johnson���who ironically was also trying to turn things around��/p>
- [By Laura Brodbeck]
Notable earnings releases expected on Tuesday include:
Caesars Entertainment Corporation (NASDAQ: CZR) is expected to report a fourth quarter loss of $1.49 on revenue of $2.12 billion, compared to last year�� loss of $3.75 on revenue of $2.02 billion. American Eagle Outfitters, Inc (NYSE: AEO) is expected to report fourth quarter EPS of $0.26 on revenue of $1.05 billion, compared to last year�� EPS of $0.55 on revenue of $1.12 billion. The Bon-Ton Stores, Inc.�(NASDAQ: BONT) is expected to report fourth quarter EPS of $2.74 on revenue of $980.95 million, compared to last year�� EPS of $3.73 on revenue of $1.03 billion.Economics
- [By Lauren Pollock]
Bon-Ton Stores Inc.(BONT) slashed its expectations for the year and the retailer warned poor winter weather in the majority of its markets led to lower traffic and hampered promotional events tied to the Christmas holiday. Shares slid 19% to $12.60 premarket.
Top Mid Cap Stocks To Buy Right Now: OXiGENE Inc.(OXGN)
OXiGENE, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics to treat cancer and eye diseases in the United States. It primarily focuses on the development of vascular disrupting agents (VDAs) that disable and destroy abnormal blood vessels, which provide solid tumors a means of growth and survival, as well as associate with visual impairment in various ophthalmological diseases and conditions. The company?s products include ZYBRESTAT, which is in fosbretabulin in anaplastic cancer of the thyroid (FACT) trial?Phase 2/3 study for the treatment of anaplastic thyroid cancer; in fosbretabulin in advanced lung oncology (FALCON) trial?Phase 2 randomized and controlled study to treat non-small cell lung cancer; in Phase 2 Simon two-stage design study for the treatment of platinum-resistant ovarian cancer; and in Phase 2 randomized controlled study to treat platinum-relapsed but platinum sensitive ovarian cancer. Its products also comprise OXi4503 that is in Phase 1 dose-escalation study for the treatment of acute myelogenous leukemia and myelodysplastic syndromes; Phase 1b dose-ranging study to treat solid tumors with hepatic tumor burden; and Phase 1 dose-escalation study for the treatment of refractory solid tumors. In addition, the company?s products consist of ZYBRESTAT, which is in Phase 2 randomized, double-masked, placebo-controlled, single-dose study for proof-of-mechanism study in polypoidal choroidal vasculopathy. OXiGENE has a strategic collaboration agreement with Symphony Capital Partners, L.P. to support the advancement of ZYBRESTAT for oncology and ophthalmology, and OXi4503. The company was founded in 1988 and is headquartered in South San Francisco, California.
Advisors' Opinion:- [By Bryan Murphy]
If you missed the recent surges from Neurometrix Inc. (NASDAQ:NURO) and/or OXiGENE Inc. (NASDAQ:OXGN), and decided to skip an entry on either or both because they were too frothy at the time, then here's some good news.... you're getting a second chance. Both NURO and OXGN are getting their proverbial second wind, and they're doing so at a price much lower than the price you would have had to pay for either just a few days ago. There's just one catch - you may want to hurry of you want in. This second wind is unfurling as rapidly as the first surges did.
- [By Bryan Murphy]
In the very short run, OXiGENE Inc. (NASDAQ:OXGN) is overbought and probably due for a setback, not unlike the all the other one-day surges and subsequent pullbacks we've seen from the stock since February of this year. Today's pop from OXGN, however, is quite different than all the rest... this time, it's got a legitimate shot at following through on the upside effort. Ergo, this little biopharma name is actually one of the market's best 'trades' right now.
- [By Wallace Witkowski]
Shares of Oxigene Inc. (OXGN) �more than doubled on very heavy volume after the microcap biotech said a mid-stage study of its drug Zybrestat, when used with Roche�� Avastin, showed increased survival in ovarian cancer patients. Oxigene shares rallied 129% to $5.55 , and were one of the most heavily traded issues after hours with more than 4.2 million shares exchanging hands.
No comments:
Post a Comment